Valneva SE (VALN) Operating Income (2021 - 2026)

Valneva SE (VALN) posted quarterly Operating Income of -$27.0 million for Q1 2026, down 297.58% year-on-year from $13.6 million in Q1 2025, and up 15.72% on a QoQ basis from -$32.0 million in Q4 2025.

Valneva SE (VALN) Operating Income (2021 - 2026) Analysis & Trends

Valneva SE (VALN) has reported Operating Income for 6 consecutive years, with -$27.0 million the latest figure, recorded in Q1 2026.

  • Quarterly Operating Income fell 297.58% year-over-year to -$27.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$113.6 million (down 64.04% YoY) and the FY2025 annual result came in at -$93.4 million, down 715.6% from the prior year.
  • Operating Income grew to -$27.0 million in Q1 2026 per VALN's latest filing, from -$32.0 million in the prior quarter.
  • Over the last five years, Operating Income for VALN reached as high as $106.2 million in Q3 2022 and fell as low as -$150.2 million in Q2 2022.
  • A 5-year average of -$19.3 million and a median of -$23.8 million in 2024 frame the typical range for Operating Income.
  • Annual changes were most pronounced in 2024 — Operating Income surged 511.54% — and 2026, when it slumped 297.58%.
  • Year by year, Operating Income stood at -$64.1 million in 2022, then jumped by 55.8% to -$28.3 million in 2023, then grew by 16.15% to -$23.8 million in 2024, then slumped by 34.62% to -$32.0 million in 2025, then climbed by 15.72% to -$27.0 million in 2026.
  • According to Business Quant data, Operating Income over the past three periods registered -$27.0 million, -$32.0 million, and -$42.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -27.75 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 249.90 Mn
4 NuCana 279.75 Bn 279.75 Bn - -3.72 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.14 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 642.90 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -32.68 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 493.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - -445.22 Mn
10 Valneva SE 803.90 Mn 680.66 Mn 5.38 Mn -26.96 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -26.96 Mn
Dec 31, 2025 -31.99 Mn
Sep 30, 2025 -42.24 Mn
Jun 30, 2025 -12.37 Mn
Mar 31, 2025 -6.78 Mn
Dec 31, 2024 -23.77 Mn
Sep 30, 2024 -14.17 Mn
Jun 30, 2024 -24.52 Mn
Mar 31, 2024 77.62 Mn
Dec 31, 2023 -28.34 Mn
Sep 30, 2023 -25.28 Mn
Jun 30, 2023 -20.93 Mn
Mar 31, 2023 -18.86 Mn
Dec 31, 2022 -64.12 Mn
Sep 30, 2022 106.19 Mn
Jun 30, 2022 -150.20 Mn
Mar 31, 2022 -20.96 Mn
Dec 31, 2021 200.52 Mn
Sep 30, 2021 -172.32 Mn
Jun 30, 2021 -62.63 Mn